Detalhe da pesquisa
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660812
2.
Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma.
Blood
; 137(9): 1154-1165, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080623
3.
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.
Ann Hematol
; 102(2): 369-383, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460794
4.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567778
5.
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Br J Cancer
; 126(5): 718-725, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802051
6.
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
Br J Haematol
; 193(1): 93-100, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33118614
7.
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma.
Am J Hematol
; 96(4): 418-427, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368455
8.
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 21(12): 1630-1642, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129376
9.
Clinical and Neuroimaging Correlates of Post-Transplant Delirium.
Biol Blood Marrow Transplant
; 26(12): 2323-2328, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961373
10.
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Cancer
; 126(19): 4332-4340, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706404
11.
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma.
Blood
; 132(24): 2546-2554, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352784
12.
Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma.
Hematol Oncol
; 38(3): 353-362, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053229
13.
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(4): 683-688, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30579965
14.
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry.
Br J Haematol
; 187(5): 602-614, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31382320
15.
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Blood
; 130(22): 2401-2409, 2017 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018077
16.
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.
Ann Hematol
; 97(12): 2425-2436, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30056582
17.
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 262-268, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856369
18.
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.
Biol Blood Marrow Transplant
; 23(7): 1151-1157, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392378
19.
Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.
Biol Blood Marrow Transplant
; 23(11): 1949-1954, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729147
20.
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.
Blood
; 126(20): 2284-90, 2015 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26384354